<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0907245514
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1985
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NORACTONE 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SPIRONOLACTONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C03DA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of your medicine is NORACTONE. The active ingredient is Spironolactone. This belong to a group<br />of medicines called potassium-sparing diuretics (water tablets), which help you lose excess fluid from your<br />body.<br />This medicine is used to:<br />□ Congestive heart failure (a condition where your heart&rsquo;s pumping action has become weak because of too<br />much fluid in your body.)<br />□ Nephrotic syndrome (a kidney disorder)<br />□ Liver cirrhosis with fluid retention (edema) and swelling of the abdomen (ascites)<br />□ A cancerous disease with swelling of the abdomen (malignant ascites)<br />□ Diagnosis and treatment of primary aldosteronism (a condition where excess hormone is produced).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take NORACTONE:<br />Do not take NORACTONE tablets and tell your doctor if you:<br />□ Are allergic (hypersensitive) to Spironolactone or any of the other ingredients in NORACTONE tablets (see<br />section 6)<br />□ Have diabetes with or without kidney problems<br />□ Have Addison&rsquo;s disease (weakness, loss of energy, low blood pressure and dark pigmentation of the skin<br />□ Have kidney problems which may be severe or worsening<br />□ Have high blood levels of potassium<br />□ Are not passing urine.<br />Take special care with NORACTONE:<br />Check with your doctor or pharmacist before taking NORACTONE tablets if you have:<br />□ A diet high in potassium<br />□ Low blood levels of sodium<br />□ Liver cirrhosis<br />□ Been passing small amounts of urine<br />□ A severe illness<br />□ Ever had too much acid in the body<br />□ An inherited disorder of the red blood pigment hemoglobin causing skin blisters, abdominal pain and<br />nervous system disorders (porphyria)<br />□ Abnormal periods or swollen breasts.<br />Taking other medicines:<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including<br />medicines obtained without a prescription. Especially:<br />□ Blood pressure lowering medicines (antihypertensives) such as ACE inhibitors (e.g. captopril or enalapril)<br />and angiotensin-II receptor antagonists (such as valsartan or losartan)<br />□ Chlorpropamide (used in diabetes)<br />□ Digoxin (used in some heart conditions)<br />□ Cyclosporine or tacrolimus (used to prevent organ transplant rejection, treat rheumatoid arthritis, eczema<br />or psoriasis)<br />□ Fludrocortisone (a corticosteroid)<br />□ Warfarin (used to thin the blood)<br />□ Other potassium-sparing diuretics (water tablets)<br />□ Lithium (used for some mental illnesses)<br />□ Non-steroidal anti-inflammatory drugs (NSAIDs) such as indometacin and mefenamic acid<br />□ Aspirin (to reduce pain, inflammation and high temperature)<br />□ Potassium supplements (potassium salts)<br />□ Noradrenalin (norepinephrine) (used for low blood pressure or heart problems)<br />□ An anesthetic<br />□ Carbenoxolone (an ulcer healing drug).<br />Taking NORACTONE with food and drink:<br />□ Swallow the tablets with water and preferably with food.<br />Pregnancy and breastfeeding:<br />Pregnancy<br />If you are pregnant or planning to become pregnant, speak to your doctor before taking this medicine.<br />Breast-feeding<br />NORACTONE tablets should not be taken if you are breast-feeding.<br />Driving and using machines:<br />NORACTONE tablets may cause dizziness or drowsiness. Make sure you are not affected before you drive<br />or operate machinery.<br />Important information about some of the ingredients of NORACTONE:<br />If you have been told you have intolerance to some sugars, contact your doctor before taking this medicine,<br />as it contains a type of sugar called lactose.<br />Interference with Tests:<br />If you are to have liver function tests, you are to be tested for diabetes or need to have other tests related to<br />diabetes, tell your doctor that you are taking NORACTONE tablets.<br />NORACTONE tablets may need to be stopped at least three days before a diabetes test.<br />Tests to be performed:<br />Your doctor may want to carry out tests to monitor the levels of fluid and chemicals in your body, especially if<br />you are elderly or have impaired liver or kidney function.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take NORACTONE tablets exactly as your doctor has told you. If you are not sure, check with your<br />doctor or pharmacist.<br />Adults:<br />□ Congestive heart failure: 100mg a day. The maintenance dose is 25- 200mg a day. In difficult or severe<br />cases, up to a maximum of 400mg a day may be taken.<br />□ Nephrotic syndrome: 100-200mg a day.<br />□ Liver cirrhosis with fluid retention and swelling of the abdomen: 100-400mg a day. Your doctor will decide<br />on the best maintenance dose for you.<br />□ A cancerous disease with swelling of the abdomen: 100-200mg a day. Your doctor will decide on the best<br />maintenance dose for you. In severe cases, up to a maximum of 400mg a day may be taken.<br />□ Primary aldosteronism diagnosis: Long test: 400mg a day for 3-4 weeks.<br />Short test: 400mg a day for 4 days.<br />□ Primary aldosteronism treatment: 100-400mg a day in preparation for surgery. If surgery is not to be<br />carried out, your doctor will decide on the best maintenance dose for you.<br />Elderly:<br />Your doctor will decide on the best dose for you. If you have severely impaired liver or kidney function, your<br />doctor may prescribe a different dose.<br />Children:<br />Usual starting dose is 3mg per kg of bodyweight a day, to be taken in divided doses. Your doctor will adjust<br />the dose depending on the response to treatment. If necessary, the tablets may be crushed and dispersed in<br />food or drink.<br />If you take more NORACTONE than you should:<br />□ If you (or someone else) swallow a lot of tablets at the same time, or you think a child may have swallowed<br />any, contact your nearest hospital casualty department or tell your doctor immediately.<br />□ Symptoms of an overdose include drowsiness, mental confusion, feeling or being sick, dizziness, diarrhea,<br />decreased blood levels of sodium, increased blood levels of potassium (symptoms include &lsquo;pins and needles&rsquo;<br />or tingling, unusual tiredness or weakness, muscular weakness, paralysis with a loss of muscle tone, muscle<br />spasm).<br />If you forget to take NORACTONE:<br />If you forget to take a dose, take it as soon as you remember it and then take the next dose at the right time.<br />Do not take a double dose to make up for a forgotten dose.<br />If you stop taking NORACTONE:<br />□ It is important to keep taking NORACTONE until your doctor tells you to stop, even if you start to feel<br />better.<br />□ If you stop taking the tablets too soon, your condition may get worse.<br />□ If you have any further questions on the use of this medicine, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, NORACTONE tablets can cause side effects, although not everybody gets them.Stop taking NORACTONE and contact your doctor at once if you develop:<br />□ High blood levels of potassium (muscle twitching or weakness, irregular heartbeat, unusual tiredness or<br />weakness, paralysis with or without loss of muscle tone, circulatory failure), especially if you have impaired<br />kidney function or a diet high in potassium.<br />Contact your doctor immediately if you:<br />□ Notice signs of an allergic reaction (hypersensitivity) such as swelling of the face, lips, tongue or throat,<br />difficulty breathing or swallowing, shock, collapse, skin rash or itching.<br />Tell your doctor or pharmacist if you notice any of the following side effects, they get worse or if you<br />notice anything not listed:<br />□ Blood: Increase in blood levels of nitrogen or urea especially in those with impaired kidney function, altered<br />numbers and types of blood cells. If you notice increased bruising, nosebleeds, sore throats or infections,<br />you should tell your doctor who may want you to have a blood test.<br />□ Metabolism and nutrition: Low blood levels of sodium, changes in the levels of chemicals in the body.<br />□ Nervous system: Lack of muscle control or coordination, drowsiness, dizziness, headache, clumsiness.<br />□ Psychiatric: Tiredness.<br />□ Liver: A poisonous effect on the liver.<br />□ Stomach and intestines: Inflammation of the stomach lining, bleeding in the stomach, stomach or intestinal<br />ulcers, stomach cramps, diarrhea, being sick.<br />□ Skin: Skin rashes including pale or red irregular raised patches with severe itching (hives), hair loss,<br />itchiness and blistering of the skin around the lips and the rest of the body (Stevens-Johnson syndrome),<br />detachment of the top layer of skin from the lower layers of skin all over the body (toxic epidermal<br />necrolysis), skin rash, fever and swelling (which could be symptoms of something more serious, drug rash<br />and eosinophilia and systemic symptoms).<br />□ Muscle and bone: Bone softening due to vitamin D deficiency.<br />□ Kidneys: Acute kidney failure particularly in those who already have impaired kidney function.<br />□ Reproductive system: Enlarged breasts in men, changes in voice pitch, reduced sexual potency in men,<br />decreased sexual ability, breast tenderness and increased hair growth in females, irregular periods,<br />sweating.<br />Tell your doctor or pharmacist if you notice any of the above side effects, they get worse or if you notice<br />anything not listed</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />□ Do not store above 30&deg;C, protect from humidity and light.<br />□ Do not use NORACTONE after the expiry date which is stated on the carton and on the blister, after<br />(EXP).Date.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to<br />dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What NORACTONE contains:<br />□ The active substance is Spironolactone. Each tablet contains 25 mg of Spironolactone.<br />□ The other ingredients are: Anhydrous Dibasic Calcium Phosphate, Lactose, Maize Starch, Sodium Lauryl<br />Sulphate, Magnesium Stearate and Colloidal Anhydrous Silica</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                NORACTONE 25 mg Tablets are white circular flat face bevelled edge tablet plain on both sides.
□ Boxes of 30 blistered tablets of NORACTONE 25 Tablets.
□ Boxes of 1000 blistered tablets of NORACTONE 25 Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian pharmaceutical manufacturing co.(P.L.C.|)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>نوراكتون هو اسم دوائك. سبايرونولاكتون هو المكوّن الفعال. وهو ينتمي إلى مجموعة من الأدوية تعرف بمدرات البول الموفرة للبوتاسيوم و<br />التي تساعدك على التخلص من السوائل الزائدة في جسمك.<br />يستخدم هذا الدواء لعلاج:<br />فشل القلب الاحتقاني (وهي الحالة التي تكون فيها عملية ضخ الدم من القلب ضعيفة بسبب كثرة تجمع السوائل في الجسم). □<br />المتلازمة الكلائية (اضطراب في الكلى). □<br />تشمع الكبد مع احتباس في السوائل (وذمة) وتورم في البطن (استسقاء). □<br />مرض سرطاني مع تورم في البطن (استسقاء خبيث). □<br />لتشخيص و علاج الألدوستيرونية الأولية (وهي الحالة المرضية التي تحدث نتيجة زيادة إفراز هرمون الألدوستيرون في الجسم).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>موانع استعمال نوراكتون:<br />لا تتناول أقراص نوراكتون و أخبر طبيبك:<br />.( إذا كنت تعاني من حساسية اتجاه سبايرونولاكتون أو لأي من مكونات أقراص نوراكتون (انظر القسم ٦ □<br />إذا كنت مصاباً بمرض السكري مع أو بدون مشاكل في الكلى. □<br />إذا كنت تعاني من مرض أديسون (ضعف عام، فقدان الطاقة، انخفاض في ضغط الدم و تصبغ داكن في الجلد). □<br />إذا كنت تعاني من مشاكل في الكلى والتي قد تكون شديدة أو في حالة تدهور. □<br />إذا كان لديك ارتفاع في مستويات البوتاسيوم. □<br />في حالة انقطاع البول (عدم التبول). □<br />الاحتياطات عند استعمال نوراكتون:<br />استشر طبيبك أو الصيدلاني قبل تناولك نوراكتون إذا:<br />كنت تتبع نظام غذائي يحتوي على كمية عالية من البوتاسيوم في الدم. □<br />كنت تعاني من انخفاض في مستويات الصوديوم. □<br />كنت تعاني تشمع الكبد. □<br />كانت كمية البول التي تخرج من الجسم قليلة. □<br />كنت تعاني من مرض شديد (وخيم). □<br />إذا عانيت في أي وقت مضى من زيادة الحموضة في الجسم. □<br />كنت تعاني من اضطراب مورث في تكوين الصبغة المكونة للهيموغلوبين مما يسبب نفطة (بثور)، آلام في البطن واضطرابات في الجهاز □<br />العصبي (البرفيرية)<br />اضطرابات في الدورة الشهرية أو تورم في الثدي □<br />تناول أدوية أخرى:<br />الرجاء إخبار الطبيب أو الصيدلي إذا كنت تأخذ أو أخذت مؤخراً أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها من دون وصفة<br />طبية، وعلى وجه الخصوص الأدوية التالية:<br />الأدوية التي تسخدم لتخفيض ضغط الدم مثل: مثبطات الإنزيم المحول للأنجيوتنسين (على سبيل المثال: كابتوبريل أو إنالابريل) و مضادات □<br />مستقبلات الأنجيوتنسين ۲ (مثل فالسارتان و لوسارتان)<br />كلوربروبامايد (يستخدم في مرض السكري) □<br />الديجوكسين (يستخدم في بعض أمراض القلب) □<br />سايكلوسبورين أو تاكروليمس (تستخدم هذه الأدوية لمنع رفض الجسم للعضو المزروع، لعلاج التهاب المفاصل الروماتويدي ، الأكزيما أو □<br />الصدفية)<br />فلودروكورتيزون (كورتيكوستيرويد) □<br />الوارفارين (يستخدم لمنع تجلط الدم) □<br />مدرات البول الأخرى الموفرة للبوتاسيوم □<br />الليثيوم (لبعض أنواع الأمراض النفسية) □<br />مضادات الالتهاب غير الستيرويدية مثل إندوميتاسين و حمض الميفينامك □<br />الأسبيرين (يستخدم لعلاج الألم، الالتهابات و ارتفاع درجة الحرارة) □<br />مكملات البوتاسيوم (أملاح البوتاسيوم) □<br />نورادرينالين (نورإيبينفرين) و الذي يستخدم لعلاج انخفاض ضغط الدم و مشاكل القلب □<br />الأدوية المخدرة □<br />كاربينوكسولون (يستخدم لعلاج القرحة) □<br />تناول نوراكتون مع الطعام والمشروبات:<br />ابلع الدواء مع الماء و يفضل تناوله مع الطعام.<br />الحمل والإرضاع:<br />الحمل<br />إذا كنت حاملاً أو تخططين للإنجاب، تحدثي إلى طبيبك قبل تناول الدواء.<br />الإرضاع<br />يجب أن لا تتناولي نوراكتون إذا كنت مرضعة.<br />قيادة السيارات واستعمال الآلات:<br />قد يسبب نوراكتون الشعور بالدوار أو النعاس لذلك يجب أن تتأكد من عدم تأثير الدواء عليك أثناء القيادة أو استخدام الآلات.<br />معلومات هامة عن بعض مكونات نوراكتون:<br />يحتوي هذا الدواء على لاكتوز، فإذا أخبرك طبيبك أنك تعاني من عدم تحمل لبعض السكريات فإنه يجب عليك استشارته قبل تناول الدواء.<br />التداخل مع بعض الفحوصات:<br />إذا كنت ستقوم ببعض الفحوصات المتعلقة بوظائف الكبد أو ستقوم بالفحص لمرض السكري أو فحوصات أخرى متعلقة بمرض السكري ، فإن<br />عليك إخبار طبيبك بأنك تتناول أقراص نوراكتون.<br />قد تحتاج للتوقف عن تناول أقراص نوراكتون لمدة لا تقل عن ثلاثة أيام قبل إجراء فحص السكري.<br />الفحوصات التي يجب القيام بها:<br />قد يحتاج طبيبك للقيام ببعض الفحوصات لمراقبة مستوى السوائل و المواد الكيميائية في الجسم, خاصة إذا كنت من كبار السن أو تعاني من<br />ضعف في وظائف الكلى أو الكبد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائماً تناول نوراكتون بالضبط كما أخبرك طبيبك. يجب عليك التحقق من طبيبك أو الصيدلاني إذا كنت غير متأكد.<br />المرضى البالغين:<br />۲۰۰ ملغم في اليوم. في الحالات المرضية الصعبة أو الشديدة قد تصل الجرعة إلى ٤۰۰ - فشل القلب الاحتقاني: ۱۰۰ ملغم في اليوم. جرعة المداومة هي ۲٥ □<br />ملغم كحد أقصى.<br />۲۰۰ ملغم في اليوم. - المتلازمة الكلائية: ۱۰۰ □<br />٤۰۰ ملغم في اليوم. سوف يقرر الطبيب جرعة المداومة المناسبة لك. - تشمع الكبد مع احتباس في السوائل وتورم في البطن: ۱۰۰ □<br />۲۰۰ ملغم في اليوم. سوف يقرر الطبيب جرعة المداومة المناسبة لك. في الحالات المرضية الشديدة قد تصل الجرعة - مرض سرطاني مع تورم في البطن: ۱۰۰ □<br />إلى ٤۰۰ ملغم كحد أقصى.<br />٤ أسابيع. - لتشخيص الألدوستيرونية الأولية: الفحص الطويل: ٤۰۰ ملغم لمدة ۳ □<br />الفحص القصير: ٤۰۰ ملغم لمدة ٤ أيام.<br />٤۰۰ ملغم في اليوم استعداداً لإجراء عملية جراحية. إذا لم يتم إجراء عملية جراحية ، سوف يقرر الطبيب جرعة المداومة - لعلاج الألدوستيرونية الأولية: ۱۰۰ □<br />المناسبة لك.<br />كبار السن (الكهول):<br />سوف يقرر الطبيب الجرعة المناسبة لك. إذا كنت تعاني من ضعف شديد في وظائف الكبد أو الكلى ، سيقوم الطبيب بوصف جرعة مختلفة لك.<br />الأطفال:<br />جرعة البداية الاعتيادية هي ۳ ملغم لكل كيلو غرام من وزن الطفل، تؤخذ على جرعات مقسمة. سوف يقوم الطبيب بتعديل الجرعة اعتماداً على استجابتك للدواء.<br />يمكن سحق القرص و يوضع في الطعام أو الشراب إذا احتاج الأمر لذلك.<br />إذا تناولت نوراكتون أكثر مما يجب:<br />اذا تناولت أنت أو شخص آخر الكثير من نوراكتون (أكثر من الجرعة المقررة) أو كنت تظن أن طفلك ابتلع أي من هذه الأقراص، فإن عليك التحدث إلى طبيبك أو<br />اذهب إلى أقرب مستشفى على الفور.<br />تشمل أعراض الجرعة الزائدة: نعاس، تشوش ذهني، غثيان أو تقيؤ، دوار، إسهال، انخفاض في مستوى الصوديوم في الدم، زيادة في مستوى البوتاسيوم<br />(الأعراض: نخز، ضعف أو تعب غير اعتيادي، ضعف في العضلات، شلل مع فقدان تناغم حركة العضلة، تشنج عضلي).<br />إذا نسيت تناول نوراكتون:<br />إذا نسيت تناول الجرعة، عليك تناولها في أقرب وقت من تذكرها. تناول جرعتك التالية في موعدها. لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.<br />إذا توقفت عن تناول نوراكتون:<br />من المهم الاستمرار في تناول نوراكتون إلى نهاية وقت المعالجة حتى لو شعرت بتحسن ،إلى حين أن يخبرك طبيبك بالتوقف عن تناوله. □<br />إذا توقفت عن تناول الدواء في وقت مبكر قد يؤدي هذا إلى تدهور حالتك المرضية. □<br />إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلاني. □</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كغيره من الأدوية، قد يسبب نوراكتون آثاراً جانبيةً، بالرغم من أنها لا تحدث للجميع.<br />يجب التوقف عن تناول نوراكتون والاتصال بطبيبك على الفور إذا حدثت معك الأعراض التالية:<br />ارتفاع مستوى البوتاسيوم في الدم: يشمل الأعراض التالية: نفضان العضلات أو ضعفها، عدم انتظام ضربات القلب،التعب أو الضعف العام □<br />غير الاعتيادي، شلل مع أو بدون فقدان تناغم حركة العضلات، فشل الدورة الدموية) وخاصة إذا كنت تعاني من ضعف في وظائف الكلى أو<br />&nbsp;تتبع نظام غذائي غني في البوتاسيوم.</p><p>اتصل بطبيبك على الفور إذا:<br />لاحظت علامات تدل على تفاعل تحسسي (فرط الحساسية) مثل تورم في الوجه أو الشفاه أو اللسان أو الحلق، وصعوبة في التنفس أو البلع، □<br />صدمة أو هبوط في الجسم ، طفح جلدي أو حكة.<br />عليك إخبار الطبيب أو الصيدلاني إذا حدثت لك أياً من الأعراض التالية أو إذا ازدادت سوءاً أو إذا لاحظت أعراض أخرى غير مذكورة في<br />النشرة:<br />الدم: زيادة في مستويات اليوريا أو النيتروجين في الدم خاصة في الأشخاص الذين يعانون من فشل في وظائف الكلى.تغيير أنواع و أعداد □<br />خلايا الدم. إذا لاحظت زيادة حدوث الكدمات، نزيف في الأنف، التهاب الحلق أو إصابته بالعدوى، يجب إخبار الطبيب الذي قد يرغب في عمل<br />بعض الفحوصات المخبرية للدم.<br />الأيض و التغذية: انخفاض مستوى الصوديوم في الدم، وتغيرات على مستوى المواد الكيميائية في الجسم. □<br />الجهاز العصبي: عدم السيطرة على العضلات أو التنسيق بين حركتها، نعاس، دوخة، صداع، و التصرف بشكل غير ملائم. □<br />التأثير النفسي: تعب □<br />الكبد: تأثير سام على الكبد. □<br />المعدة والأمعاء: التهاب بطانة المعدة، نزيف في المعدة، قرحة في المعدة أو الأمعاء، مغص في البطن، إسهال، تقيؤ. □<br />الجلد: طفح جلدي بما في ذلك شحوب أو ظهور بقع حمراء مرتفعة على سطح الجلد غير منظمة مع حكة شديدة (الشرى) وفقدان الشعر، حكة □<br />وتقرح الجلد حول الشفتين و بقية الجسم (متلازمة ستيفنز جونسون)، انفصال الطبقة العليا من الجلد عن الطبقة السفلى في جميع أنحاء الجسم<br />(تقشر الأنسجة المتموتة البشروية التسممي)، طفح جلدي وحمى وتورم (والتي قد تكون أعراض لأمر أكثر خطورة، طفح دوائي، كثرة<br />اليوزينيات وأعراض شاملة) .<br />العضلات والعظام: تليين العظام بسبب نقص فيتامين د. □<br />الكلى: الفشل الكلوي الحاد وخاصة في المرضى الذين لديهم اختلال في وظائف الكلى قبل البدء بتناول الدواء. □<br />الجهاز التناسلي: تضخم الثديين عند الرجال، تغيرات في طبقة الصوت، انخفاض الفاعلية الجنسية لدى الرجال، وانخفاض القدرة الجنسية، □<br />إيلام في الثدي، زيادة نمو الشعر عند الإناث، عدم انتظام الدورة الشهرية، التعرق.<br />أخبر طبيبك أو الصيدلي إذا لاحظت أياً من الآثار الجانبية المذكورة أعلاه أو إذا ازدادت هذه الأعراض سوءاً أو لاحظت أعراض أخرى غير<br />مذكورة في النشرة:</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول الأطفال. □<br />لا يحفظ بدرجة حرارة أعلى من ۳۰ &deg;م، يحفظ بعيداً عن الضوء والرطوبة. □<br />لا ينبغي استعمال نوراكتون بعد تاريخ انتهاء الصلاحية الموجود على العلبة وعلى شريط الدواء. □<br />لا ينبغي التخلص من الأدوية من خلال مياه الصرف الصحي أو المنزلي. اسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد مطلوبة.<br />سوف تساعد هذه الإجراءات على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>على ماذا يحتوي نوراكتون:<br />المادة الفعالة هي سبايرونولاكتون. كل قرص يحتوي على ۲٥ ملغم من سبايرونولاكتون.<br />المكونات الأخرى هي: فوسفات الكالسيوم ثنائي القاعدة اللامائي، لاكتوز، نشا الذرة، سلفات لوريل الصوديوم، ستيارات المغنيزيوم، سيليكا<br />غروية لامائية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص نوراكتون ۲٥ ملغم هي أقراص بيضاء دائرية مسطحة حادة الحواف غير منقوشة من الطرفين. □<br />علب تحتوي على ۳۰ قرص من أقراص نوراكتون ۲٥ المحفوظة في أشرطة. □<br />علب تحتوي على ۱۰۰۰ قرص من أقراص نوراكتون ۲٥ المحفوظة في أشرطة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الاردنية لانتاج الادوية المساهمة العامة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            حزيران ۲۰۲۰
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Noractone 25 mg Tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains Spironolactone 25 mg
Inactive Ingredients:

Inactive ingredients(s) and amount (s) per unit dose:
Ingredient	mg/Tab
Anhydrous Dibasic Calcium Phosphate 	51.0
Lactose 	88.6
Maize Strach 	85.0
Sodium Lauryl Sulphate 	2.5
Magnesium Stearate 	1.4
Colloidal Anhydrous Silica	1.0

  *For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Noractone  25 Tablet :

White circular flat face bevelled edge tablet, plain on both sides

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1) Congestive heart failure.</p><p>2) Nephrotic syndrome.</p><p>3) Hepatic cirrhosis with ascites and oedema.</p><p>4) Malignant ascites.</p><p>5) The diagnosis and treatment of primary aldosteronism</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Route of administration</strong>: Oral</p><p>Noractone tablets should always be administered with fluid and preferably with food to aid absorption.<br />Adults:<br />Congestive heart failure:<br />Usually 100mg daily. In difficult or severe cases the dosage may be gradually increased up to 400mg daily. When oedema is controlled, the usual maintenance level is 25 &ndash; 200mg daily.<br />Nephrotic syndrome:<br />Usually 100-200mg daily. Spironolactone has not been shown to be anti- inflammatory, nor to affect the basic pathological process. Its use is only advised if glucocorticoids by themselves are insufficiently effective.<br />Hepatic cirrhosis with ascites and oedema:<br />If urinary Na+/K+ ratio is greater than 1.0; 100mg daily. If the ratio is less than 1.0; 200-400mg daily. Maintenance doses should be individually determined.<br />Malignant ascites:<br />Initial dosage is usually 100-200mg daily. In severe cases the dosage may be gradually increased up to 400mg daily. When oedema is controlled, dosage should be individually determined.<br />Diagnosis and treatment of primary aldosteronism:<br />Spironolactone may be employed as an initial diagnostic measure to provide presumptive evidence of primary hyperaldosternonism while patients are on normal diets.</p><p>Long test:<br />Spironolactone is administered at a daily dosage of 400mg for 3-4 weeks. Correction of hypokalaemia and of hypertension provides presumptive evidence for the diagnosis of primary hyperaldosteronism.<br />Short test:<br />Spironolactone is administered at a daily dosage of 400mg for 4 days. If serum potassium increases during spironolactone administration but drops when spironolactone is discontinued, a presumptive diagnosis of primary hyperaldosteronism should be considered.<br />After the diagnosis of hyperaldosteronism has been established by more definitive testing procedures, spironolactone may be administered in doses of 100-400mg daily in preparation for surgery. For patients who are considered unsuitable for surgery, spironolactone may be employed for long-term maintenance therapy at the lowest effective dosage determined for the individual patient.<br />Elderly:<br />It is recommended that treatment should commence with the lowest dose and be titrated upwards as required in order to achieve maximum benefit. Caution should be exercised in severe hepatic and renal impairment which may alter drug metabolism and excretion.<br />Children:<br />Initially daily dosage should provide 3mg of spironolactone per kg bodyweight in divided doses. Dosage should be adjusted in accordance with response and tolerance. If necessary the tablets may be crushed and taken dispersed in food or drink.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Spironolactone therapy is contraindicated in the following:
• Anuria (patients are at greater risk of developing hyperkalaemia)
• Active renal insufficiency, rapidly progressing or severe impairment of renal function (spironolactone may aggravate electrolyte imbalance and the risk of developing hyperkalaemia is increased)
• Hyperkalaemia (spironolactone may further increase serum potassium concentrations)
• Addison's disease
• Hypersensitivity to spironolactone or any of the ingredients in the product
• Diabetes mellitus, especially in patients with confirmed or suspected renal insufficiency
• Diabetic nephropathy (increased risk of hyperkalaemia. Spironolactone should be discontinued at least 3 days prior to a glucose tolerance test because of the risk of severe hyperkalaemia).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Patients with rare hereditary problems of galactose intolerance, the lapp lactase deficiency or glucose &ndash; galactose malabsorption should not take this medicine.<br />&bull; Patients receiving spironolactone should be carefully evaluated for possible disturbances of fluid and electrolyte balance, particularly in the elderly and in those with significant renal and hepatic impairment.<br />&bull;Hyperkalaemia may occur in patients with impaired renal function or excessive potassium intake and can cause cardiac irregularities which may be fatal. Should hyperkalaemia develop, spironolactone should be discontinued, and if necessary, active measures taken to reduce the serum potassium to normal. Dilutional hyponatraemia may be induced especially when spironolactone is concurrently administered with other diuretics.<br />&bull; Care should be taken in patients suffering from hyponatraemia.<br />&bull; Reversible increases in blood urea have been reported with spironolactone therapy, particularly in the presence of impaired renal function.<br />&bull; Reversible hyperchloraemic metabolic acidosis, usually in association with hyperkalaemia has been reported to occur in some patients with decompensated hepatic cirrhosis, even in the presence of normal renal function.<br />&bull; Caution is required in severely ill patients and those with relatively small urine volumes who are at greater risk of developing hyperkalaemia.<br />&bull; Caution is required in patients with a predisposition to metabolic or respiratory acidosis. Acidosis potentiates the hyperkalaemic effects of spironolactone and spironolactone may potentiate acidosis.<br />&bull; Spironolactone has been shown to produce tumours in rats when administered at high doses over a long period of time. The significance of these findings with respect to clinical use is not certain. However, the long-term use of spironolactone in young patients requires careful consideration of the benefits and the potential hazard involved.<br />&bull; Caution should be exercised in patients diagnosed with porphyria as spironolactone is considered unsafe in these patients.<br />&bull; Care should be taken in patients suffering from menstrual abnormalities or breast enlargement.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ACE inhibitors - since ACE inhibitors decrease aldosterone production they should not&nbsp;routinely be used with spironolactone, particularly in patients with marked renal impairment.<br />&bull; Angiotensin-II receptor antagonists &ndash; concurrent administration of angiotensin-II receptor antagonists, e.g. valsartan, losartan, and spironolactone may result in an increase in serum potassium levels. If concurrent use is necessary, monitor serum potassium levels.<br />&bull; Antihypertensives - potentiation of the effect of antihypertensive drugs occurs and their dosage may need to be reduced when spironolactone is added to the treatment regime, and then adjusted as necessary.<br />&bull; Anti-diabetics &ndash; administration with chlorpropamide may increase risk of hyponatraemia.<br />&bull; Aspirin - may reduce the diuretic effect of spironolactone.<br />&bull; Cardiac glycosides - spironolactone has been reported to increase serum digoxin concentration and to interfere with certain serum digoxin assays. In patients receiving digoxin and spironolactone, the digoxin response should be monitored by means other than serum digoxin concentrations, unless the digoxin assay used has been proven not be affected by spironolactone therapy. If it proves necessary to adjust the dose of digoxin, patients should be carefully monitored for evidence of enhanced or reduced digoxin effect.<br />&bull; Ciclosporin - co-administration of potassium-sparing diuretics with ciclosporin may result in hyperkalaemia. Avoid concurrent use of spironolactone and ciclosporin. If concurrent therapy is necessary, monitor serum potassium levels for persistent elevations in patients.<br />&bull; Corticosteroids - co-administration of spironolactone with fludrocortisone may result in a paradoxical dose-related increase in urinary potassium excretion. If concomitant administration is necessary, closely monitor serum potassium levels.<br />&bull; Coumarins - in patients receiving oral anticoagulant therapy with warfarin, the prothrombin time ratio or INR (international normalised ratio) should be monitored with the addition and withdrawal of treatment with spironolactone, and should be reassessed periodically during concurrent therapy. Adjustments of the warfarin dose may be necessary in order to maintain the desired level of anticoagulation.<br />&bull; Diuretics - spironolactone should not be administered concurrently with other potassium- sparing diuretics as this may induce hyperkalaemia. Potassium canrenoate, a metabolite of spironolactone, has been shown to cause myeloid leukaemia in rats.<br />&bull; Lithium - concurrent use of lithium and spironolactone may result in increased lithium concentrations and lithium toxicity (weakness, tremor, excessive thirst, and confusion) due to decreased lithium excretion. If concomitant therapy is necessary monitor serum lithium levels within the first five to seven days of adding or discontinuing spironolactone and periodically thereafter. Lower lithium doses may be required with concomitant spironolactone therapy.</p><p>&bull; NSAIDs - may attenuate the natriuretic efficacy of diuretics due to inhibition of intrarenal synthesis of prostaglandins. There may be an increased risk of nephrotoxicity and hyperkalaemia when NSAIDs, notably indometacin are used with spironolactone.<br />Indometacin and mefenamic acid, inhibit the excretion of canrenone reducing the diuretic effect.<br />&bull; Potassium salts &ndash; potassium supplements are contraindicated except in cases of initial potassium depletion. If potassium supplementation is considered essential, serum electrolytes should be monitored.<br />&bull; Sympathomimetics - spironolactone reduces vascular responsiveness to noradrenaline (norepinephrine); caution should be exercised in the management of patients subjected to regional or general anaesthesia.<br />&bull; Tacrolimus - spironolactone should not be used in patients undergoing therapy with tacrolimus as concomitant use has resulted in mild to severe hyperkalaemia.<br />&bull; Ulcer healing drugs - as carbenoxolone may cause sodium retention and thus decrease the effectiveness of spironolactone, concurrent use of the two agents should be avoided.<br />&bull; In fluorimetric assays spironolactone may interfere with the estimation of compounds with similar fluorescence characteristics.<br />&bull; Liver function tests &ndash; spironolactone may enhance the metabolism of antipyrine used in liver function tests.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Spironolactone or its metabolites may cross the placental barrier. With spironolactone feminisation has been observed in male rat foetuses. Spironolactone should be used with caution in pregnant women, weighing the potential risk to the mother and foetus against the possible benefits. Canrenone, a metabolite of spironolactone, appears in breast milk, therefore an alternative method of infant feeding should be instituted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be warned that they may experience dizziness or drowsiness when taking this medicine. They should make sure they are not affected before driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Blood and lymphatic system disorders: agranulocytosis, eosinophilia and thrombocytopenia have been reported rarely. Spironolactone may cause transient elevations in blood urea nitrogen (BUN) especially in patients with renal impairment. Hyponatraemia has been reported rarely.<br />&bull; Hypersensitivity: these occur rarely and are usually mild but very occasionally may be severe causing swelling, shock and collapse. Shortness of breath, skin rash or itching has been reported rarely.</p><p>&bull; Metabolism and nutrition disorders: hyperkalemia and hyponatraemia has been reported rarely. Electrolyte disturbances.<br />&bull; Nervous system disorders: ataxia, drowsiness, dizziness, headache and clumsiness have been reported although these are less common.<br />&bull; Psychiatric disorders: lethargy.<br />&bull; Cardiac disorders: severe hyperkalaemia may result in paralysis, flaccid paraplegia and cardiac arrhythmias with subsequent cardiovascular collapse. This can be fatal in patients with impaired renal function.<br />&bull; Hepato &ndash; biliary disorders: hepatotoxicity has been reported.<br />&bull; Gastrointestinal disorders: gastritis, gastric bleeding, stomach cramps, diarrhoea, vomiting and ulceration are more frequent effects.<br />&bull; Skin and subcutaneous tissue disorders: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic symptoms (DRESS), urticaria and alopecia has been reported rarely, skin rashes have also been reported.<br />&bull; Musculoskeletal, connective tissue and bone disorders: osteomalacia.<br />&bull; Renal and urinary disorders: acute renal failure, particularly in those with pre-existing renal impairment.<br />&bull; Reproductive system and breast disorders: gynaecomastia may develop in association with the use of spironolactone. Development appears to be related to both dosage level and duration of therapy and is usually reversible once therapy is discontinued. In rare instances some breast enlargement may persist. Alteration in voice pitch may also occur on rare occasions which may not be reversible. Impotence and decreased sexual ability has been reported. This is usually reversible on discontinuation of spironolactone. Breast tenderness and increased hair growth in females, irregular menstrual periods and sweating have been reported<br />Saudi Arabia: To report any side effect(s): National Pharmacovigilance Center (NPC): Fax: +966-11-205-7662, SFDA Call center: 19999, E mail: npc.drug@sfda.gov.sa, Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Toxic effects of overdosage are drowsiness, mental confusion, nausea, vomiting, dizziness or diarrhoea. Hyponatraemia or hyperkalaemia may be induced but these effects are unlikely to be associated with acute overdosage. Symptoms of hyperkalaemia may manifest as paraesthesia, lassitude and muscular weakness, flaccid paralysis or muscle spasm and may be difficult to distinguish clinically from hypokalaemia.<br />No specific antidote has been identified. Improvement may be expected on&nbsp;cessation of therapy. Electrocardiographic changes are the earliest specific signs of potassium disturbances. General supportive measures include replacement of fluids and electrolytes may be indicated. For hyperkalaemia, reduce potassium intake, administer potassium-excreting diuretics, intravenous glucose with regular insulin, or oral ion-exchange resins</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong></p><p>&nbsp;</p><p>ATC CODE: C03D A01</p><p>&nbsp;</p><p>Spironolactone is a steroid with a structure resembling that of the natural adrenocorticoid hormone, aldosterone. It acts as a competitive inhibitor of aldosterone and acts on the distal portion of the renal tubule thereby increasing sodium and water excretion and reducing potassium excretion. It is classed as a potassium sparing diuretic or aldosterone antagonist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption :<br />Spironolactone is incompletely but fairly rapidly absorbed from the gastrointestinal tract and the extent of absorption will depend on the particle size and formulation and is improved after food. Bioavailability is estimated from 60 to 90%. Time to peak plasma concentration is approximately one hour.<br />Distribution :<br />Although the plasma half life of spironolactone itself is short (1.3 hours) the half lives of the active metabolites are longer (ranging from 2.8 to 11.2 hours).<br />Spironolactone is estimated to be 90% protein bound. Volume of distribution, extent of tissue accumulation and ability to cross the blood brain barrier are not known.<br />Spironolactone or its metabolites may cross the placental barrier and canrenone is secreted breast milk. Spironolactone is known to have a slow onset of action two to three days and a slow diminishment of action.<br />Metabolism:<br />The main site of biotransformation is the liver where it is metabolised, to 80% sulphur containing metabolities such as 7 alpha- thiomethylspironolactone and canrenone (20%). Many of these metabolities also have a diuretic-activity. Canrenone, which is an active metabolite, has a biphasic plasma half life of about 4 - 17 hours.<br />Elimination &ndash; Spironolactone is excreted in the urine and faeces in the form of metabolites.<br />The renal action of a single dose of spironolactone reaches its peak after 7 hours, and activity persists for at least 24 hours</p><p>4-12 Preclinical safety data<br />Carcinogenicity spironolactone has been shown to produce tumours in rats when administered at high doses over a long period of time. The significance of these findings with respect to clinical use in not certain. However the long term use of spironolactone in young patients requires careful consideration of the benefits and the potential hazard involved. Spironolactone or its metabolities may cross the placental barrier. With spironolactone, feminisation has been observed in male rat foetuses. The use of spironolactone in pregnant women requires that the anticipated benefit be weighed against the possible hazards to the mother and foetus.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenicity spironolactone has been shown to produce tumours in rats when administered at high doses over a long period of time. The significance of these findings with respect to clinical use in not certain. However the long term use of spironolactone in young patients requires careful consideration of the benefits and the potential hazard involved. Spironolactone or its metabolities may cross the placental barrier. With spironolactone, feminisation has been observed in male rat foetuses. The use of spironolactone in pregnant women requires that the anticipated benefit be weighed against the possible hazards to the mother and foetus</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Anhydrous Dibasic Calcium Phosphate</p><p>Lactose</p><p>Maize Starch</p><p>Sodium Lauryl Sulphate</p><p>Magnesium Stearate</p><p>Colloidal Anhydrous Silica</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Two  years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store<strong> </strong>above 30&ordm;C, protect from humidity and light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Noractone&nbsp; 25 mg &nbsp;</strong>Tablets are packed in boxes of 30 Tablets blistered in aluminium foil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of accordance with local requirements.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd.
PO Box 151
Um Al-Amad 16197
Jordan


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2020.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>